164 related articles for article (PubMed ID: 22529914)
1. CXCL12 and [N33A]CXCL12 in 5637 and HeLa cells: regulating HER1 phosphorylation via calmodulin/calcineurin.
Rigo A; Gottardi M; Damiani E; Bonifacio M; Ferrarini I; Mauri P; Vinante F
PLoS One; 2012; 7(4):e34432. PubMed ID: 22529914
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level.
Rigo A; Ferrarini I; Innamorati G; Vinante F
Oncotarget; 2018 Jun; 9(48):28830-28841. PubMed ID: 29989007
[TBL] [Abstract][Full Text] [Related]
3. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
4. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
5. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
6. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
[TBL] [Abstract][Full Text] [Related]
7. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
Gravel S; Malouf C; Boulais PE; Berchiche YA; Oishi S; Fujii N; Leduc R; Sinnett D; Heveker N
J Biol Chem; 2010 Dec; 285(49):37939-43. PubMed ID: 20956518
[TBL] [Abstract][Full Text] [Related]
8. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
9. Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7.
Ehrlich A; Ray P; Luker KE; Lolis EJ; Luker GD
Biochem Pharmacol; 2013 Nov; 86(9):1263-71. PubMed ID: 23973527
[TBL] [Abstract][Full Text] [Related]
10. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
11. Imaging ligand-dependent activation of CXCR7.
Luker KE; Gupta M; Steele JM; Foerster BR; Luker GD
Neoplasia; 2009 Oct; 11(10):1022-35. PubMed ID: 19794961
[TBL] [Abstract][Full Text] [Related]
12. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.
Kumar P; Lau CS; Mathur M; Wang P; DeFea KA
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C346-57. PubMed ID: 17442737
[TBL] [Abstract][Full Text] [Related]
14. β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4.
D'Agostino G; Artinger M; Locati M; Perez L; Legler DF; Bianchi ME; Rüegg C; Thelen M; Marchese A; Rocchi MBL; Cecchinato V; Uguccioni M
Front Immunol; 2020; 11():550824. PubMed ID: 33072091
[TBL] [Abstract][Full Text] [Related]
15. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
[TBL] [Abstract][Full Text] [Related]
16. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.
Drury LJ; Ziarek JJ; Gravel S; Veldkamp CT; Takekoshi T; Hwang ST; Heveker N; Volkman BF; Dwinell MB
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17655-60. PubMed ID: 21990345
[TBL] [Abstract][Full Text] [Related]
17. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.
Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU
J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
[TBL] [Abstract][Full Text] [Related]
19. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
20. Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor.
McCormick PJ; Segarra M; Gasperini P; Gulino AV; Tosato G
PLoS One; 2009 Dec; 4(12):e8102. PubMed ID: 19956569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]